Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca’s ovarian cancer drug Olaparib gets NICE approval

pharmaceutical-technologyJuly 30, 2019

Tag: AstraZeneca , NICE , ovarian cancer drug

PharmaSources Customer Service